← Russell 3000 cross-section

CLB Core Laboratories Inc. /DE/

Trailing twelve months to 2026-06-30 · as filed 2026-07-30, not restated
Energy

Scale

Market cap
$552m
Revenue TTM
$519m
Net income TTM
$24m
Free cash flow
$15m
Composite score
50.6
Sector rank
#2360

Valuation

P / E
22.6
EV / EBITDA
10.3
EV / sales
1.2
FCF yield
2.74%
Earnings yield vs 10-yr
-0.31pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
4.7%
EBITDA margin
12.1%
ROE
8.9%
ROIC
13.1%
Revenue growth
0.3%

Insider activity, last 90 days

Net open-market
$0.05m
Buyers
1
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

For the three months ended June 30, 2026, service revenue was $94.3 million, a decrease of 2% year-over-year and flat sequentially. Year-over-year, revenues decreased primarily due to lower activity levels in the international markets partially offset by increased activity in the U.S. market. International revenue was negatively impacted by the Middle East conflict that began in the first quarter of 2026 and other ongoing geopolitical conflicts in the Middle East and between Russia and Ukraine. Sequentially, service revenue was flat primarily due to increased activity in several international regions offset by decreased activity in the U.S. markets. …Core Laboratories Inc. /DE/, 10-Q, period ended 2026-06-30, filed 2026-07-30

Read the full passage →